Health Care: Drugs

Cardiome Pharma Corp (CRME: NASDAQ)

$6.755 -0.105 | -1.53%
07/24/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 6.86
52 Week High 11.00
52 Week Low 1.90
Avg. Daily Vol. (Mil) 0.07
Beta (3 year) 2.07
Share Related Items
Mkt Cap (Mil) 113.33
Shares Out (Mil) 16.52
Float (Mil) 10.69
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.50
Current Ratio 2.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 9.41
Price/Book 3.51
Price/Cash Flow -7.20
Per Share Data
Earnings -1.31
Sales 0.73
Book Value 1.95
Cash Flow -0.95
Business Summary
Cardiome Pharma Corp is a specialty pharmaceutical company engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.
General Information
6190 Agronomy Road
Suite 405
Vancouver, BC V6T 1Z3
www.cardiome.com
Industry : Drugs
Sector: Health Care
Employees: 75
CEO: Dr. William L. Hunter M.
Short Interest
Current Month (Mil) 0.09
Previous Month (Mil) 0.12
Short Interest Ratio (Days) 1.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -32.50
Return on Investments -51.90
Profitability
Gross Margin 79.80
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CRME

Latest CRME Headlines from TheStreet

More Financial News for CRME

Press Releases for CRME

See All Press Releases

Partner Headlines for CRME

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter